Non-surgical treatments for the management of early osteoarthritis.

Giuseppe Filardo, Elizaveta Kon, Umile Giuseppe Longo, Henning Madry, Paolo Marchettini, Antonio Marmotti, Dieter Van Assche, Giacomo Zanon, Giuseppe M Peretti

Journal: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2017;24(6):1775-85

PMID: 27043347

Abstract

Non-surgical treatments are usually the first choice for the management of knee degeneration, especially in the early osteoarthritis (OA) phase when no clear lesions or combined abnormalities need to be addressed surgically. Early OA may be addressed by a wide range of non-surgical approaches, from non-pharmacological modalities to dietary supplements and pharmacological therapies, as well as physical therapies and novel biological minimally invasive procedures involving injections of various substances to obtain a clinical improvement and possibly a disease-modifying effect. Numerous pharmaceutical agents are able to provide clinical benefit, but no one has shown all the characteristic of an ideal treatment, and side effects have been reported at both systemic and local level. Patients and physicians should have realistic outcome goals in pharmacological treatment, which should be considered together with other conservative measures. Among these, exercise is an effective conservative approach, while physical therapies lack literature support. Even though a combination of these therapeutic options might be the most suitable strategy, there is a paucity of studies focusing on combining treatments, which is the most common clinical scenario. Further studies are needed to increase the limited evidence on non-surgical treatments and their combination, to optimize indications, application modalities, and results with particular focus on early OA. In fact, most of the available evidence regards established OA. Increased knowledge about degeneration mechanisms will help to better target the available treatments and develop new biological options, where preliminary results are promising, especially concerning early disease phases. Specific treatments aimed at improving joint homoeostasis, or even counteracting tissue damage by inducing regenerative processes, might be successful in early OA, where tissue loss and anatomical changes are still at very initial stages.

Address: Biomechanics Lab - II Clinic, Rizzoli Orthopaedic Institute, Bologna, Italy.; Biomechanics Lab - II Clinic, Rizzoli Orthopaedic Institute, Bologna, Italy. [email protected].; University Campus Bio-Medico of Rome, Rome, Italy.; Center of Experimental Orthopaedics, Department of Orthopaedic Surgery, Saarland University Medical Center, Homburg/Saar, Germany.; Pain Medicine, Department of Neurology, Ospedale San Raffaele, Milan, Italy.; Pain Pathophysiology and Therapy Programme, University of Southern Switzerland, Manno, Switzerland.; Department of Orthopaedics and Traumatology, University of Torino, Turin, Italy.; Department of Rehabilitation Sciences, Research Group of Musculoskeletal Rehabilitation, KU Leuven, Louvain, Belgium.; Department of Rheumatology, University Hospital Leuven, Campus Gasthuisberg, Louvain, Belgium.; IRCCS, Fondazione Policlinico San Matteo, Pavia, Italy.; IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.